H.R. 2285: Strategies to Address Antimicrobial Resistance Act

Jun 06, 2013
Referred to Committee
1% chance of being enacted
Track this bill
Jim Matheson
Representative for Utah's 4th congressional district
Read Text »
Last Updated
Jun 06, 2013
32 pages
Related Bills
H.R. 2400 (111th) was a previous version of this bill.

Referred to Committee
Last Action: May 13, 2009


This bill was assigned to a congressional committee on June 6, 2013, which will consider it before possibly sending it on to the House or Senate as a whole.

Introduced Jun 06, 2013
Referred to Committee Jun 06, 2013
Reported by Committee ...
Passed House ...
Passed Senate ...
Signed by the President ...

4% chance of getting past committee.
1% chance of being enacted.

Only 11% of bills made it past committee and only about 3% were enacted in 2011–2013. [show factors | methodology]

Full Title

To amend the Public Health Service Act to enhance efforts to address antimicrobial resistance, and for other purposes.


No summaries available.

4 cosponsors (4D) (show)

House Energy and Commerce


The committee chair determines whether a bill will move past the committee stage.

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.


Get a bill status widget for your website »


Click a format for a citation suggestion:


H.R. stands for House of Representatives bill.

A bill must be passed by both the House and Senate in identical form and then be signed by the president to become law.

The bill’s title was written by its sponsor.

GovTrack’s Bill Summary

We don’t have a summary available yet.

Library of Congress Summary

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.

Strategies to Address Antimicrobial Resistance Act - Amends the Public Health Service Act to reauthorize through FY2018 and revise a program to combat antimicrobial resistance.
Requires the Secretary of Health and Human Services (HHS) to direct the Assistant Secretary of Health to establish the Antimicrobial Resistance Office. Requires the Secretary to establish the Public Health Antimicrobial Advisory Board to advise the Director of the Office (Director).
Requires the Director to update the Public Health Action Plan to Combat Antimicrobial Resistance within one year. Requires the Antimicrobial Resistance Task Force to review, discuss, and further develop the Action Plan.
Authorizes the Food and Drug Administration (FDA) to consult with the Director of the Antimicrobial Resistance Office concerning the pending application of any new human or animal antimicrobial drugs.
Requires the Public Health Antimicrobial Advisory Board to make recommendations to the Secretary and the Antimicrobial Resistance Office regarding issues such as research priorities and implementation of the Action Plan. Requires the Secretary, acting through the Director of the National Institutes of Health (NIH), to develop an antimicrobial resistance strategic research plan.
Gives the Director of the Antimicrobial Resistance Office direct authority over specified antimicrobial resistance activities of the Secretary. Revises demonstration programs to require the Secretary to award grants to promote the uptake and measurement of antimicrobial stewardship programs in health care facilities. Defines "antimicrobial stewardship" to mean coordinated interventions designed to improve and measure the appropriate use of antimicrobial agents.
Requires the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), to:
(1) pilot and test health care quality measures to help providers, facilities, and health systems measure and benchmark appropriate antimicrobial use;
(2) develop methods to help providers, facilities, and health systems measure and improve antimicrobial use;
(3) establish at least 10 Antimicrobial Resistance Surveillance and Laboratory Network sites;
(4) work with state health departments to support regional prevention collaboratives designed to interrupt and prevent the transmission of significant antibiotic resistant pathogens being transmitted across health care settings in a geographic region.
Requires the Secretary, acting through the Director of the National Institute of Allergy and Infectious Diseases, to establish a Clinical Trials Network on Antibacterial Resistance and a Leadership Group for the Network.
Requires the Director of the CDC to: (1) work with various entities to obtain reliable and comparable human antimicrobial drug consumption data by state or metropolitan area, (2) intensify and expand efforts to collect antimicrobial resistance data, (3) report on key trends and major issues related to antimicrobial resistance and use in the United States.
Requires the National Coordinator for Health Information Technology to work with the Director of the CDC to determine how best antimicrobial use, susceptibility, and resistance data can be incorporated into meaningful use reports.

House Republican Conference Summary

The summary below was written by the House Republican Conference, which is the caucus of Republicans in the House of Representatives.

No summary available.

House Democratic Caucus Summary

The House Democratic Caucus does not provide summaries of bills.

So, yes, we display the House Republican Conference’s summaries when available even if we do not have a Democratic summary available. That’s because we feel it is better to give you as much information as possible, even if we cannot provide every viewpoint.

We’ll be looking for a source of summaries from the other side in the meanwhile.

Use the comment space below for discussion of the merits of H.R. 2285 with other GovTrack users.
Your comments are not read by Congressional staff.

comments powered by Disqus